Travere Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Jan. 02, 2024 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced that Eric Dube, Ph.D., president and chief executive officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 3:45 p.m. PT.
Related news for (TVTX)
- Travere Therapeutics Submits sNDA to FDA for Approval of FILSPARI® (sparsentan) for the Treatment of FSGS
- Travere Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
- Travere Therapeutics to Submit sNDA for FILSPARI® (sparsentan) in FSGS
- Travere Therapeutics Provides Corporate Update and 2025 Outlook
- travere therapeutics reports third quarter 2024 financial results